News
The move follows an announcement by Secretary Robert F. Kennedy Jr. that the FDA will be conducting a review of mifepristone.
Nearly two years after overturning Roe v. Wade, the high court is still settling disputes over reproductive care — including ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results